Progress towards elimination goals for viral hepatitis

Andrea L Cox1, Manal H El-Sayed2, Jia-Horng Kao3,4

  • 1Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. acox@jhmi.edu.

Insights

Experts question the feasibility of eliminating viral hepatitis by 2030, citing progress gaps. The focus remains on hepatitis B virus and hepatitis C virus elimination strategies for the next decade.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health Policy

Background:

  • Viral hepatitis, particularly hepatitis B virus (HBV) and hepatitis C virus (HCV), represents a significant global health burden, comparable to HIV, malaria, and tuberculosis in mortality.
  • The World Health Organization set a goal in 2016 for Member States to eliminate viral hepatitis as a public health threat by 2030.

Purpose of the Study:

  • To assess the feasibility of achieving viral hepatitis elimination by the 2030 target.
  • To identify key areas of progress and critical focus points for viral hepatitis elimination efforts over the next decade and beyond.

Main Methods:

  • A viewpoint piece soliciting opinions from leading scientists and clinicians in the viral hepatitis field.
  • Analysis of current policy and progress in relation to the 2030 elimination goal.

Main Results:

  • While progress has been made, significant policy and implementation gaps persist, raising questions about the attainability of the 2030 deadline.
  • Expert opinions highlight the need for sustained focus and strategic interventions to bridge these gaps.

Conclusions:

  • Achieving viral hepatitis elimination by 2030 faces considerable challenges, necessitating a re-evaluation of strategies and intensified efforts.
  • Continued research, policy development, and clinical advancements are crucial for the long-term goal of viral hepatitis eradication.